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SUMMARY
1. The serotonin1A (5-HT1A) receptors are members of a superfamily of seven-trans-
membrane-domain receptors that couple to G-proteins. They appear to be involved in
various behavioral and cognitive functions. Mutagenesis and modeling studies point out
that the ligand-binding sites in serotonin receptors are located in the transmembrane
domain. However, these binding sites are not very well characterized. Since disulfide bonds
and sulfhydryl groups have been shown to play vital roles in the assembly, organization,
and function of various G-protein-coupled receptors, we report here the effect of disulfide
and sulfhydryl group modifications on the agonist and antagonist binding activity of 5-
HT1A receptors from bovine hippocampus.
2. DTT or NEM treatment caused a concentration-dependent reduction in specific
binding of the agonist and antagonist in 5-HT1A receptors from bovine hippocampal native
and solubilized membranes. This is supported by a concomitant reduction in binding af-
finity.
3. Pretreatment of the receptor with unlabeled ligands prior to chemical modifications
indicate that the majority of disulfides or sulfhydryl groups that undergo modification
giving rise to inhibition in binding activity could be at the vicinity of the ligand-binding sites.
4. In addition, ligand-binding studies in presence of GTP--S, a nonhydrolyzable
analogue of GTP, indicate that sulfhydryl groups (and disulfide bonds to a lesser extent)
are vital for efficient coupling between the 5-HT1A receptor and the G-protein.
5. Our results point out that disulfide bonds and sulfhydryl groups could play an
important role in ligand binding in 5-HT1A receptors.
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INTRODUCTION
Serotonin (5-hydroxytryptamine or 5-HT)3 is an intrinsically fluorescent (Chatto-
padhay et al., 1996), biogenic amine which acts as a neurotransmitter and is
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found in a wide variety of sites in the central and peripheral nervous systems (Jacobs
and Azmitia, 1992). It mediates a variety of physiological responses in distinct cell
types. Serotonergic signaling appears to play a key role in the generation and modula-
tion of various cognitive and behavioral functions including sleep, mood, pain, addic-
tion, locomotion, sexual activity, depression, anxiety, alcohol abuse, aggression,
learning, and memory (Artigas et al., 1996; Ramboz et al., 1998; Rocha et al., 1998;
Casadio et al., 1999). Disruptions in serotonergic systems have been implicated in
the etiology of mental disorders such as schizophrenia, migraine, depression, suicidal
behavior, infantile autism, eating disorders, and obsessive-compulsive disorder
(Heisler et al., 1998; Parks et al., 1998; Ramboz et al., 1998).
Serotonin exerts its diverse actions by binding to distinct cell-surface receptors
which have been classified into many groups (Zifa and Fillion, 1992; Peroutka,
1993). Serotonin receptors are members of a superfamily of seven transmembrane
domain receptors (Strader et al., 1995) that couple to GTP-binding regulatory
proteins (G-proteins). Among the various types of serotonin receptors, the G-
protein-coupled 5-HT1A receptor subtype has been the most extensively studied.
The reasons for this include:
1. The availability of a selective ligand (8-OH-DPAT) allows extensive
biochemical, physiological, and pharmacological characterization of the receptor
(Gozlan et al., 1983).
2. Certain 5-HT1A agonists exert anxiolytic and antidepressant effects (Blier
et al., 1990). As a result, the 5-HT1A receptors have become an important target
in the development of therapeutic agents to treat neuropsychiatric disorders
such as anxiety and depression. The 5-HT1A receptors are also implicated in
regulation of blood pressure, feeding, temperature regulation (Dourish et al.,
1987), and regulation of working memory (Ohno and Watanabe, 1996).
3. It was the first serotonin receptor to be cloned and sequenced (Kobilka
et al., 1987; Fargin et al., 1988; Albert et al., 1990). The human, rat, and mouse
5-HT1A receptors have been cloned and their amino acid sequences deduced
(Fargin et al., 1988; Albert et al., 1990; Charest et al., 1993). The cloning of the
5-HT1A receptor gene has shown that it belongs to the superfamily of G-protein-
coupled receptors, with 50% amino acid homology with the 2-adrenergic receptor
in the transmembrane domain. Furthermore, the receptor has been stably ex-
pressed in a number of neural and nonneural cell lines (Banerjee et al., 1993).
4. It was the first serotonin receptor for which polyclonal antibodies were
obtained (Fargin et al., 1988; El Mestikawy et al., 1990) allowing their visualization
at the subcellular level in various regions of the brain. The 5-HT1A receptor gene
has also been recently implicated in Tourette’s syndrome, a common hereditary
motor and vocal tic disorder (Lam et al., 1996).
We earlier partially purified and solubilized the 5-HT1A receptor from bovine
hippocampus in a functionally active form (Chattopadhyay and Harikumar, 1996)
and showed modulation of ligand binding by metal ions, guanine nucleotide, and
alcohols (Harikumar and Chattopadhyay, 1998a,b, 1999, 2000). Evidence from muta-
genesis (Ho et al., 1992; Chanda et al., 1993; Kuipers et al., 1997) and molecular
modeling studies (Sylte et al., 1996; Bremner et al., 1997; Kuipers et al., 1997) have
shown that the ligand-binding sites in serotonin receptors in general, and 5-HT1A
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receptors in particular, are located in the transmembrane domain. However, since
the 5-HT1A receptor has not been purified to homogeneity and high-resolution
structural data are lacking, these binding sites are not very well characterized.
Disulfide bonds and sulfhydryl groups have been shown to play vital roles in the
assembly, organization, and function of various G-protein-coupled receptors (Kami-
kubo et al., 1988; Karnik et al., 1988; Emerit et al., 1991; Javitch et al., 1994; Lin et
al., 1996; Nenonene et al., 1996; Gaibelet et al., 1997; Martini et al., 1997; Brandt
et al., 1999). In this paper, we examine the role of disulfide bonds and sulfhydryl
groups in the binding activity of agonist and antagonist to 5-HT1A receptors from
bovine hippocampus by chemical modification of these groups.
MATERIALS AND METHODS
Materials
Serotonin, iodoacetamide, polyethylenimine, sucrose, sodium azide, Tris,
MgCl2, CHAPS, EDTA, EGTA, L-DTT, NEM, and PMSF were obtained from
Sigma Chemical Co. (St. Louis, MO). GTP--S was from Boehringer Mannheim
(Germany). p-MPPI was from Research Biochemicals International (Natick, MA)
and was a kind gift from Dr. V. Bakthavachalam (National Institute of Mental
Health Chemical Synthesis Program). [3H]8-OH-DPAT (specific activity 127.0 Ci/
mmol) and [3H]p-MPPF (specific activity 64.6 Ci/mmol) were purchased from Du-
Pont New England Nuclear (Boston, MA). GF/B glass microfiber filters were from
Whatman International (Kent, UK). BCA reagent kit for protein estimation was
obtained from Pierce (Rockford, IL). Fresh bovine brains were obtained from a local
slaughterhouse within 10 min of death and the hippocampal region was carefully
dissected out. The hippocampi were immediately flash-frozen in liquid nitrogen
and stored at 70C till further use. Stock solution of DTT was in water. Stock
solution of NEM was prepared in water with traces of ethanol. The ethanol content
in the assay tubes (for NEM-treated samples) was negligible (generally less than
1% v/v) and control studies showed that this did not cause any significant change
in binding activity of the receptor (Harikumar and Chattopadhyay, 1998b).
Preparation of Native Hippocampal Membranes
Native hippocampal membranes were prepared as described earlier (Hariku-
mar and Chattopadhyay, 1998a). In short, bovine hippocampal tissue (100g) was
homogenized as 10% (w/v) in a polytron homogenizer in buffer A (2.5 mM Tris,
0.32 M sucrose, 5 mM EDTA, 5 mM EGTA, 0.02% sodium azide, 0.24 mM PMSF,
10 mM iodoacetamide, pH 7.4). The homogenate was centrifuged at 900  g for
10 min at 4C. The supernatant was filtered through four layers of cheese cloth and
the pellet was discarded. The supernatant was further centrifuged at 50,000  g
for 20 min at 4C. The resulting pellet was suspended in 10 vol of buffer B (50 mM
Tris, 1 mM EDTA, 0.24 mM PMSF, 10 mM iodoacetamide, pH 7.4) using a hand-
held Dounce homogenizer and centrifuged at 50,000  g for 20 min at 4C. This
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procedure was repeated until the supernatant was clear. The final pellet (native
membrane) was resuspended in a minimum volume of 50 mM Tris buffer (pH 7.4),
homogenized using a Dounce homogenizer, flash-frozen in liquid nitrogen, and
stored at 70C. The membrane preparation thus obtained was used either directly
for receptor binding after preincubation with DTT or NEM or for solubilization.
Solubilization of Native Membranes
Solubilization of native membranes using CHAPS was carried out as described
previously (Harikumar and Chattopadhyay, 1998b). Native membranes (2 mg/
ml total protein) were incubated with 5 mM CHAPS either in buffer C (50 mM
Tris, 1 mM EDTA, 10 mM MgCl2, pH 7.4) for agonist-binding studies, or in buffer
D (50 mM Tris, 1 mM EDTA, pH 7.4) for antagonist-binding studies for 30 min
at 4C with occasional shaking. The membranes were sonicated (5 sec) using a
Branson model 250 sonifier and mildly homogenized using a hand-held Dounce
homogenizer (five times) at the begining and the end of the incubation period.
After incubation for 30 min, the contents were centrifuged at 100,000  g for 1 hr.
The clear supernatant was carefully removed from the pellet and used immediately
for receptor binding after preincubation with DTT or NEM.
Chemical Modifications and Receptor-Binding-Assays
Receptor-Binding-Assays for agonist and antagonist were carried out as de-
scribed earlier (Harikumar and Chattopadhyay, 1998b). Briefly, tubes in duplicate
containing 1 mg of total protein (in case of native membranes) or 500 l of the
CHAPS-solubilized membrane in a total volume of 1 ml of buffer C for agonist
and buffer D for antagonist was used for the assays. The tubes were preincubated
for 30 min at room temperature with various concentrations of DTT or NEM. The
final concentration of DTT or NEM in the assay tubes ranged from 1 nM to 1 M.
After 30 min the tubes were further incubated with the radiolabeled agonist [3H]8-
OH-DPAT (final concentration in the assay tube 0.29 nM) for 1 hr at room tempera-
ture. The modifying agents (DTT or NEM) were not added to the control samples.
Nonspecific binding was determined by performing the assay in the presence of 10
M unlabeled 5-HT. The incubation was terminated by rapid filtration under vac-
uum in a Millipore multiport filtration apparatus through Whatman GF/B (1.0 m
pore size) 2.5-cm-diameter glass microfiber filters which were presoaked in 0.3%
polyethylenimine for 3 hr (Bruns et al., 1983). The filters were then washed three
times with 3 ml of ice-cold water and dried, and the retained radioactivity was
measured in a Packard Tri-Carb 1500 scintillation counter using 5 ml of scintilla-
tion fluid.
Antagonist-binding assays in presence of various concentrations of DTT or
NEM were performed as above using [3H]p-MPPF as the radioligand. The assay
tubes contained 0.5 nM [3H]p-MPPF in a total volume of 1 ml of buffer D. The
modifying agents (DTT or NEM) were not added to the control samples. Nonspecific
binding was determined by performing the assay in the presence of 10 M unlabeled
p-MPPI.
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In some experiments (Table III) the native membrane was pretreated with
unlabeled agonist (5-HT) or antagonist (p-MPPI) by incubation with 1 M of 5-
HT (in buffer C) or p-MPPI (in buffer D) for 30 min at room temperature. After
the incubation the membrane suspension was centrifuged at 20,000  g for 10 min
at 4C. The pellet was resuspended in the respective buffer and incubated with
DTT or NEM (at their respective IC50 values) for 30 min at room temperature and
ligand-binding assays were carried out as above.
For experiments in which GTP--S was used (Table IV) the ligand-binding
assays were performed either in presence of GTP--S alone as described earlier
(Harikumar and Chattopadhyay, 1999) or after preincubation with DTT or NEM
(at their respective IC50 values) for 30 min at room temperature in presence of GTP-
-S. Protein concentration was determined using BCA reagent (Smith et al., 1985).
Saturation Binding Assays
Saturation binding assays were carried out using varying concentrations (0.1–
7.5 nM) of radiolabeled agonist ([3H]8-OH-DPAT) or antagonist ([3H]p-MPPF)
using native membranes or chemically modified (DTT- or NEM-treated) mem-
branes containing 1 mg of total protein. Nonspecific binding was measured in the
presence of 10M unlabeled 5-HT (for agonist) or p-MPPI (for antagonist). Binding
assays were carried out at room temperature as mentioned above. The specific
DTT or NEM concentration at which the assays were done was the half maximal
inhibition concentration (IC50 value) taken from Table I. Binding data were analyzed
as described by Hulme (1990). The concentration of bound ligand was calculated
from the equation
[RL*]  109  B/(V  SA  2220) M
where B is bound radioactivity in disintegrations per minute (dpm) (i.e., total
dpm  nonspecific dpm), V is the assay volume in ml, and SA is the specific activity
of the radioligand. Scatchard plots (i.e., plots of [RL*]/[L*] vs. RL*) were analyzed
using Sigma-Plot (version 3.1) on an IBM PC. The dissociation constants Kd were
obtained from the negative inverse of the slopes, determined by linear regression
Table I. IC50 for Inhibiton of Specific [3H]8-OH-DPAT and [3H]p-
MPPF Binding to 5-HT1A Receptors from Bovine Hippocampal Native
and Solubilized Membrane by DTT and NEMa
IC50 (mM)
DTT NEM
Native membrane
[3H]8-OH-DPAT 10  1.10 0.1  0.01
[3H]p-MPPF 20  2.80 40  0.63
Solubilized membrane
[3H]8-OH-DPAT 0.82  0.03 0.03  0.002
[3H]p-MPPF 1.20  0.08 0.32  0.042
a All values are the average of three independent experiments. See
Materials and Methods for other details.
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analysis of the plots (r  0.90–0.99). The Bmax values were obtained from the
intercept on the abscissa. The Bmax values reported in Table II have been normalized
with respect to the amount of native membrane used. The binding parameters
shown in Table II were obtained by averaging the results of three independent
experiments, while saturation binding data shown in Figs. 5 and 6 are from represen-
tative experiments.
RESULTS
Inhibition of Specific Agonist-Binding Activity Following DTT and NEM
Treatment of Native and Solubilized Membranes
Figure 1 shows the effect of increasing concentrations of DTT and NEM on
the specific binding of the agonist [3H]8-OH-DPAT to the 5-HT1A receptor from
bovine hippocampal native membranes. As shown in the figure, treatment with
DTT or NEM results in a concentration-dependent inhibition of agonist binding.
However, NEM appears to be more effective than DTT in producing the inhibition
in agonist binding since more inhibition is observed at lower concentrations of
NEM. This is supported by the respective half maximal inhibition concentration
(IC50) values shown in Table I. The IC50 value obtained for NEM (0.1 mM) is about
100 times less than that for DTT (10 mM) in the native membrane. This points
out that the agonist-binding site, possibly localized in the hydrophobic integral
membrane portion of the receptor, is relatively easily accessed by NEM, which
would partition better into the membrane because of its relatively nonpolar nature
compared to DTT (also see below).
Figure 2 shows the concentration-dependent inhibition of specific [3H]8-OH-
DPAT binding in hippocampal membranes solubilized by the zwitterionic detergent
CHAPS. Interestingly, while both DTT and NEM treatment show inhibition in
specific [3H]8-OH-DPAT binding in solubilized membranes, the concentrations of
the modifying agents required to produce a given magnitude of inhibition were
found to be lower than what were needed in case of the native membrane. Accord-
Table II. Affinity and Bmax Values of [3H]8-OH-DPAT and [3H]p-MPPF Binding to 5-HT1A Receptors
from Bovine Hippocampal Native Membrane Following DTT and NEM Treatmenta
[3H]8-OH-DPAT [3H]p-MPPF
Kd Bmax Kd Bmax
(nM) (fmol/mg of protein) (nM) (fmol/mg of protein)
Native membrane 1.18  0.19 108.0  13.10 0.67  0.04 220.3  13.80
DTT 3.18  0.77 106.0  11.20 0.83  0.06 162.0  14.10
NEM 2.60  0.26 89.0  4.22 1.13  0.13 66.0  9.70
a The binding parameters represent the mean SE of duplicate points from three independent experi-
ments, while saturation binding data shown in Figs. 5 and 6 are from representative experiments. The
concentrations of DTT and NEM used were 10 and 0.1 mM for [3H]8-OH-DPAT binding and 20 and
40 mM for [3H]p-MPPF binding, which correspond to the respective IC50 values (see Table I). See
Materials and Methods for other details.
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Fig. 1. Effect of increasing concentrations of DTT () and NEM
() on the specific binding of the agonist [3H]8-OH-DPAT to the
5-HT1A receptor from bovine hippocampal native membranes. Val-
ues are expressed as a percentage of the specific binding obtained
in the absence of any modifying agent (DTT or NEM). The data
points are the means  SE of duplicate points from three indepen-
dent experiments. See Materials and Methods for other details.
Fig. 2. Effect of increasing concentrations of DTT () and NEM
() on the specific binding of the agonist [3H]8-OH-DPAT to the
5-HT1A receptor from bovine hippocampal solubilized membranes.
Values are expressed as a percentage of the specific binding obtained
in the absence of any modifying agent (DTT or NEM). The data
points are the means  SE of duplicate points from three indepen-
dent experiments. See Materials and Methods for other details.
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ingly, the corresponding IC50 values (see Table I) in case of the solubilized membrane
showed a marked reduction (0.82 and 0.03 mM for DTT and NEM, respectively).
This could be due to the general difference in organization and packing pattern in
the native and solubilized membranes. The lipids in the solubilized membrane are
loosely packed, resulting in increased partitioning of the externally added modifying
agents (DTT or NEM). In addition, the solubilized membrane has a higher water
content (Harikumar and Chattopadhyay, 1998b; Rukmini, R., Shanti, K., and Chat-
topadhyay, A., unpublished observations) and this also helps in partitioning of
relatively polar molecules such as DTT. It is perhaps for this reason that the
reduction in IC50 value obtained with the solubilized membrane (when compared
to native membrane IC50 values) in case of DTT treatment is higher (12-fold reduc-
tion) than in case of NEM treatment (3-fold).
Inhibition of Specific Antagonist-Binding Activity Following DTT and NEM
Treatment of Native and Solubilized Membranes
Although selective 5-HT1A agonists such as 8-OH-DPAT were discovered some
time ago (Gozlan et al., 1983), the development of selective 5-HT1A antagonists
have been relatively slow and less successful. Recently two specific antagonists for
the 5-HT1A receptor, p-MPPI and p-MPPF, have been introduced (H. F. Kung et
al., 1994; M.-P. Kung et al., 1994, 1995; Thielen and Frazer, 1995). These compounds
bind specifically to 5-HT1A receptor with high affinity. The effect of increasing
concentrations of DTT and NEM on the specific binding of the antagonist [3H]p-
MPPF to the 5-HT1A receptor in native hippocampal membranes is shown in Fig.
3. DTT or NEM treatment results in a concentration-dependent inhibition of antago-
nist binding similar to the inhibition in agonist binding described above. However,
a major difference observed in the case of inhibition of specific [3H]p-MPPF binding
is that both DTT and NEM appear to have comparable efficiency in inhibiting
antagonist binding. This is evident from the respective IC50 values (see Table I),
which differ only by a factor of two. This supports our earlier observation (Hariku-
mar and Chattopadhyay, 1998b) of overlapping, but not identical binding sites for
agonist and antagonist in the 5-HT1A receptor. We postulated, based on ethanol
effects on the agonist and antagonist binding, that the antagonist-binding site is
more polar in nature than the agonist-binding site and may even have an interfacial
location, i.e., at a shallow location in the membrane compared to the agonist site.
This is consistent with our present observation (see Fig. 1 and Table I) of a large
difference in IC50 values for DTT and NEM treatment for agonist inhibition in the
native membrane. It should be noted here that different binding domains for agonists
and antagonists were shown for the kappa opioid receptor (Kong et al., 1994).
The concentration-dependent inhibition of specific [3H]p-MPPF binding in
hippocampal CHAPS-solubilized membranes is shown in Fig. 4. The IC50 values in
the case of antagonist binding also (see Table I) showed a marked reduction (1.20
and 0.32 mM for DTT and NEM, respectively) probably because of altered packing
of lipids in solubilized membranes giving rise to increased accessibility of the modi-
fying agents to the binding site.
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Fig. 3. Effect of increasing concentrations of DTT () and NEM () on the
specific binding of the antagonist [3H]p-MPPF to the 5-HT1A receptor from
bovine hippocampal native membranes. Values are expressed as a percentage
of the specific binding obtained in the absence of any modifying agent (DTT
or NEM). The data points are the means  SE of duplicate points from three
independent experiments. See Materials and Methods for other details.
Fig. 4. Effect of increasing concentrations of DTT () and NEM () on
the specific binding of the antagonist [3H]p-MPPF to the 5-HT1A receptor
from bovine hippocampal solubilized membranes. Values are expressed as
a percentage of the specific binding obtained in the absence of any modifying
agent (DTT or NEM). The data points are the means  SE of duplicate
points from three independent experiments. See Materials and Methods for
other details.
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Changes in Binding Affinity and Sites upon DTT and NEM Treatment by
Saturation Binding Analysis
Figures 5 and 6 show Scatchard analyses of the specific binding of [3H]8-OH-
DPAT and [3H]p-MPPF to the 5-HT1A receptors in bovine hippocampal membranes
following DTT and NEM treatment. The binding parameters under these conditions
are summarized in Table II. The specific binding affinity of [3H]8-OH-DPAT shows
considerable reduction upon chemical modification by DTT or NEM. This change
in binding affinity supports the inhibition in agonist binding observed upon DTT
or NEM treatment (Fig. 1). However, the accompanying reduction in the number
of maximum binding sites Bmax is rather small. Table II also shows a reduction in
binding affinity of [3H]p-MPPF when the native membrane was treated with DTT
or NEM, which is in agreement with Fig. 3. Interestingly, there is a concomitant
decrease in the number of maximum binding sites Bmax in this case.
Effect of Pretreatment with Unlabeled Ligands Prior to Chemical Modifications
on Specific Agonist- and Antagonist-Binding Activity
The inhibition in ligand binding due to chemical modifications of the receptor
could have its origin in the chemical modification of the disulfides or sulfhydryl
groups in the vicinity of the ligand-binding sites which would alter the conformation
and hence binding of the receptor. Alternatively, DTT and NEM could affect the
disulfides or sulfhydryl groups in other regions of the protein (not close to the
Fig. 5. Scatchard analysis of specific binding of the agonist [3H]8-OH-DPAT
to the 5-HT1A receptor from bovine hippocampal native membranes () and
in DTT-treated () and NEM-treated () membranes. The concentrations of
DTT and NEM used were 10 and 0.1 mM, which correspond to the respective
IC50 values (see Table I). Data shown are from a representative experiment
and each point is the mean of duplicate determinations. The concentration of
[3H]8-OH-DPAT ranged from 0.1 to 7.5 nM. See Materials and Methods for
other details.
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Fig. 6. Scatchard analysis of specific binding of the antagonist [3H]p-MPPF to
the 5-HT1A receptor from bovine hippocampal native membranes () and in
DTT-treated () and NEM-treated () membranes. The concentrations of
DTT and NEM used were 20 and 40 mM, which correspond to the respective
IC50 values (see Table I). Data shown are from a representative experiment
and each point is the mean of duplicate determinations. The concentration
of [3H]p-MPPF ranged from 0.1 to 7.5 nM. See Materials and Methods for
other details.
binding sites), which in turn could induce a conformation that inhibits ligand binding.
In order to distinguish between these two possible mechanisms, we preincubated
the native membrane containing the 5-HT1A receptor with excess unlabeled ligand
(serotonin or p-MPPI) before DTT or NEM treatment. The concentrations of the
modifying agents were such that in the absence of any preincubation with unlabeled
ligand, 50% of specific binding (normalized to the control native membrane arbi-
trarily taken as 100%) would have been expected since IC50 values of the modifying
agents were used (see Table I). Table III shows that in all cases the specific binding
obtained was higher than 50%, implying that the presence of the unlabeled ligand
at the binding site protected the inhibition of ligand binding to a considerable
extent. While this indicates that the majority of disulfides or sulfhydryl groups that
undergo modification giving rise to inhibition in binding activity could be at the
vicinity of the ligand-binding sites, the involvement of disulfides or sulfhydryl groups
from other regions of the receptor cannot be ruled out (see Discussion).
Effect of GTP--S Addition Following Chemical Modifications on Specific
Agonist- and Antagonist-Binding Activity
Since most seven-transmembrane-domain receptors are coupled to G-proteins
(Clapham, 1996), guanine nucleotides are known to regulate agonist binding. The
5-HT1A receptor is negatively coupled to the adenylate cyclase system through G-
proteins (Emerit et al., 1990). We reported (Harikumar and Chattopadhyay, 1999)
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Table III. Specific Binding of [3H]8-OH-DPAT and [3H]p-MPPF
to 5-HT1A Receptors from Bovine Hippocampal Native Membrane
Preincubated with 5-HT and p-MPPI Followed by DTT and NEM
Treatmenta
Modifying agent Specific binding (%)
Control (native membrane) 100
Control  5-HT  DTT 84  0.6
Control  5-HT  NEM 67  1.8
Control  p-MPPI  DTT 78  4.4
Control  p-MPPI  NEM 88  1.8
a The binding parameters represent the mean SE of duplicate points
from three independent experiments. The concentration of 5-HT or
p-MPPI used was 1 M in all cases. The concentrations of DTT and
NEM used were 10 and 0.1 mM for [3H]8-OH-DPAT binding, and
20 and 40 mM for [3H]p-MPPF binding, which correspond to the
respective IC50 values (see Table I). See Materials and Methods for
other details.
that agonist binding to the 5-HT1A receptor in bovine hippocampal native mem-
branes is sensitive to guanine nucleotides, while antagonist binding to the 5-HT1A
receptor was found to be insensitive to guanine nucleotides. This was monitored
by studying the effect of GTP--S, a nonhydrolyzable analogue of GTP, on agonist
and antagonist binding to the receptor. Our results showed that the specific binding
of the agonist was inhibited with increasing concentrations of GTP--S and antago-
nist binding was unaltered and remained invariant over a large range of GTP--S
concentrations. In order to investigate the effect of chemical modifications on G-
protein-coupling in 5-HT1A receptors, we checked whether there was any change
in specific binding of [3H]8-OH-DPAT and [3H]p-MPPF to 5-HT1A receptors in
presence of GTP--S following treatment with DTT or NEM. The results of these
experiments are shown in Table IV. The specific [3H]8-OH-DPAT binding shows
Table IV. Specific Binding of [3H]8-OH-DPAT and [3H]p-MPPF to
5-HT1A Receptors in Presence of GTP--S from Bovine Hippocampal
Native Membrane Following DTT and NEM Treatmenta
Specific binding (%)
Contition [3H]8-OH-DPAT [3H]p-MPPF
GTP--S (55 nM) 48.0  0.6 98.7  5.1
DTT 49.7  1.1 43.7  0.8
DTT  GTP-V-S 20.1 2.0 45.8  1.1
NEM 49.3  4.1 45.7  1.0
NEM  GTP--S 12.8  2.2 38.7  3.2
a The binding parameters represent the mean SE of duplicate points
from four independent experiments. The concentrations of DTT and
NEM used were 10 and 0.1 mM for [3H]8-OH-DPAT binding and
20 and 40 mM for [3H]p-MPPF binding, which correspond to the
respective IC50 values (see Table I). The concentration of GTP--S
used was 55 nM, which corresponds to50% inhibition in [3H]8-OH-
DPAT binding (Harikumar and Chattopadhyay, 1999). See Materials
and Methods for other details.
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further reduction in presence of GTP--S following chemical modifcations (DTT
or NEM treatment). This indicates that sulfhydryl groups (and disulfide bonds to
a lesser extent since the reduction in activity is less with DTT treatment) are
important for efficient coupling between the receptor and the G-protein as shown
for the 2-adrenoceptors (Kitamura and Nomura, 1987). Table IV also shows that in
accordance with our earlier results (Harikumar and Chattopadhyay, 1999), specific
[3H]p-MPPF binding was not altered in the presence ofGTP--S and there was
no significant decrease in binding in the presence of GTP--S following DTT or
NEM treatment.
DISCUSSION
The overall goal of this paper has been to evaluate the role of disulfide and
sulfhydryl groups in ligand binding in 5-HT1A receptors from bovine hippocampus
by chemical modification of these groups. As mentioned earlier, disulfide bonds
and sulfhydryl groups have been shown to play vital roles in the assembly, organiza-
tion, and function of various G-protein-coupled receptors (Kamikubo et al., 1988;
Karnik et al., 1988; Emerit et al., 1991; Javitch et al., 1994; Lin et al., 1996; Nenonene
et al., 1996; Gaibelet et al., 1997; Martini et al., 1997; Brandt et al., 1999). Our results
show concentration-dependent inhibition of agonist and antagonist binding to 5-
HT1A receptors when the membrane was treated with DTT or NEM either in its
native state or when solubilized using the zwitterionic detergent CHAPS. This
inhibition in ligand binding is supported by a reduction in binding affinity. Further,
experiments in which the receptor was pretreated with the unlabeled ligand prior
to chemical modifications indicate that while the majority of disulfides or sulfhydryl
groups that undergo modification giving rise to inhibition in binding activity could be
at the vicinity of the ligand-binding sites, the involvement of disulfides or sulfhydryl
groups from other regions of the receptor cannot be ruled out. In addition, ligand-
binding studies in the presence of GTP--S, a nonhydrolyzable analogue of GTP,
indicate that sulfhydryl groups (and disulfide bonds to a lesser extent) are vital for
efficient coupling between the 5-HT1A receptor and the G-protein.
It has been reported recently that the ligand 8-OH-DPAT also binds to 5-HT7
receptors in addition to binding to the 5-HT1A receptor (Vanhoenacker et al., 2000).
However, the specificity of this interaction is relatively modest and the affinity is
found to be almost two orders of magnitude lower than what is known for the 5-
HT1A receptor (Ruat et al., 1993). In addition, analysis of the distribution pattern
of the 5-HT7 receptor in the brain show that the receptor is mainly localized in the
hypothalamus, thalamus, and cortical regions (Vanhoenacker et al., 2000), as op-
posed to the 5-HT1A receptor, which displays a predominant hippocampal localiza-
tion (Palacios et al., 1990).
The 5-HT1A receptors are members of a superfamily of seven-transmembrane-
domain receptors that couple to G-proteins. Mutagenesis studies have revealed
that several residues which are highly conserved among members of the G-protein-
coupled receptor family possess important structural and functional roles (Kobilka,
1992; Strader et al., 1994). Interestingly, one of the common structural features
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shared by many G-protein-coupled seven-transmembrane-domain receptors is a
pair of conserved cysteine residues in the first and second extracellular loops which
are often linked as a disulfide bond (Dohlman et al., 1990; Savarese et al., 1992;
Lin et al., 1996; Ji et al., 1998). The decrease in ligand binding observed here could
probably be due to the destabilization of the disulfide linkage which may hold the
active conformation of the receptor together as shown earlier in the case of the 2-
adrenergic receptor (Lin et al., 1996).
The alignment of seven-transmembrane-domain G-protein-coupled receptor
sequences indicates that the hydrophilic components of the transmembrane seg-
ments are the most likely site of agonist–receptor interactions. Studies using the
-adrenergic, -adrenergic, and muscaranic acetylcholine receptors have demon-
strated that the location of the binding site inside the membrane is a common
feature of all these receptors (Ostrowski et al., 1992). The agonists for these receptors
contain an amine group that is proposed to form a complex with the negatively
charged aspartate residue in the third transmembrane domain. This is believed to
constitute one of the epitopes necessary for high-affinity binding. The primary
structures of the members of the G-protein-coupled receptor family indicate that
this binding mechanism is conserved in all the receptors that have a charged amine
group as a feature of their activating ligand. All cloned 5-HT receptors also contain
the aspartic acid residue in the third transmembrane domain at a comparable
position (Wang et al., 1993). It is of interest to note here that the putative topological
model for the 5-HT1A receptor shows a total of eight cysteine residues in the
transmembrane domain of which the maximum number (four) of cysteine residues
are localized in the third transmembrane domain where the conserved aspartic acid
residue is also located (Boess and Martin, 1994). Site-directed mutation studies of
these transmembrane cysteine residues could provide vital information about the
possible role of these residues in ligand binding.
In summary, our results point out that disulfide and sulfhydryl groups play an
important role in the agonist and antagonist binding to 5-HT1A receptors and efficient
G-protein coupling. These results are relevant to ongoing analyses of the structure–
function relationships for G-protein-coupled receptors in ligand-binding processes
in general, and the importance of disulfide and sulfhydryl groups in ligand binding
in case of the 5-HT1A receptors in particular.
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